SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Data provided by Kaleidoscope.